Sergio Yelamos-Martinez

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 75 publications

Serum biomarkers remain stable after transitioning from intravenous to subcutaneous natalizumab in multiple sclerosis.

Serum biomarkers remain stable after transitioning from intravenous to subcutaneous natalizumab in multiple sclerosis.

Journal: Journal of neurology
Published: April 28, 2026

How do neurologists perceive the organization and functioning of multiple sclerosis care units?

How do neurologists perceive the organization and functioning of multiple sclerosis care units?

Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: October 02, 2025

Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple Sclerosis.

Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple Sclerosis.

Journal: European journal of neurology
Published: August 31, 2025

Proteomic profile of CSF obtained at the time of diagnosis determines amyotrophic lateral sclerosis progression and survival: CXCL7 levels in disease prognosis and survival.

Proteomic profile of CSF obtained at the time of diagnosis determines amyotrophic lateral sclerosis progression and survival: CXCL7 levels in disease prognosis and survival.

Journal: Brain pathology (Zurich, Switzerland)
Published: August 12, 2025

Authors' response to comment on "Second-line pharmacological treatment strategies for trigeminal neuralgia: A retrospective comparison of lacosamide, gabapentin, and baclofen".

Authors' response to comment on "Second-line pharmacological treatment strategies for trigeminal neuralgia: A retrospective comparison of lacosamide, gabapentin, and baclofen".

Journal: Headache
Published: July 20, 2025

The 2024 McDonald criteria show comparable sensitivity to previous criteria for late-onset multiple sclerosis.

The 2024 McDonald criteria show comparable sensitivity to previous criteria for late-onset multiple sclerosis.

Journal: Multiple sclerosis and related disorders
Published: June 26, 2025

Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome.

Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome.

Journal: JAMA neurology
Published: June 02, 2025

3D T1 turbo spin echo improves detection of gadolinium-enhancing multiple-sclerosis lesions.

3D T1 turbo spin echo improves detection of gadolinium-enhancing multiple-sclerosis lesions.

Journal: Insights into imaging
Published: May 29, 2025

Benign multiple sclerosis and long-term outcomes after 30 years.

Benign multiple sclerosis and long-term outcomes after 30 years.

Journal: Journal of neurology
Published: May 28, 2025

Posterior Reversible Encephalopathy Syndrome as a Complication of Essential Thrombocythemia: A Case Report and Literature Review.

Posterior Reversible Encephalopathy Syndrome as a Complication of Essential Thrombocythemia: A Case Report and Literature Review.

Journal: Cureus
Published: April 18, 2025

Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: April 09, 2025

Neurologists' Openness to Evidence-Based Innovation in Multiple Sclerosis Care: Individual and Structural Determinants.

Neurologists' Openness to Evidence-Based Innovation in Multiple Sclerosis Care: Individual and Structural Determinants.

Journal: Neuropsychiatric disease and treatment
Published: February 23, 2025
Showing 1-12 of 75

Last Updated: 09/26/2026